EDIT
Editas Medicine·NASDAQ
--
--(--)
--
--(--)
2.31 / 10
Underperform
Technically, Editas Medicine is struggling (score 2.31/10). The last five days show two bearish signals (Bearish Engulfing, Long Lower Shadow) versus none bullish; Bearish Engulfing has a 0% win rate and negative return, while Long Lower Shadow is neutral. Marubozu White is bullish but insufficient to counterbalance the downturn. The overall trend is poor, highlighting downside risk.
Analysis Checks(0/3)
Long Lower Shadow
Score1.93/10
Win Rate43.66%
Hist. Signals71
Avg Return-0.23%
Score1.93/10
Win Rate43.66%
Hist. Signals71
Avg Return-0.23%
Marubozu White
Score4/10
Win Rate46.67%
Hist. Signals15
Avg Return4.99%
Score4/10
Win Rate46.67%
Hist. Signals15
Avg Return4.99%
Bearish Engulfing
Score1/10
Win Rate0.00%
Hist. Signals7
Avg Return-4.24%
Score1/10
Win Rate0.00%
Hist. Signals7
Avg Return-4.24%
Long Lower Shadow
Score1.93/10
Win Rate43.66%
Hist. Signals71
Avg Return-0.23%
Score1.93/10
Win Rate43.66%
Hist. Signals71
Avg Return-0.23%
Bearish Engulfing
Score1/10
Win Rate0.00%
Hist. Signals7
Avg Return-4.24%
Score1/10
Win Rate0.00%
Hist. Signals7
Avg Return-4.24%
Marubozu White
Score4/10
Win Rate46.67%
Hist. Signals15
Avg Return4.99%
Score4/10
Win Rate46.67%
Hist. Signals15
Avg Return4.99%
What is the current technical signals for EDIT?
- EDIT presents a Underperform setup with a Technical Score of 2.31/10. Key technical indicators highlight an RSI of 39.62 and a MACD of -0.05, with the trend anchored by the 50-Day SMA at 2.20. Traders should monitor key support at 1.57 and resistance at 1.86.
